Insider trade

Sensus Healthcare (SRTS): Director bought ~$11K

Eric Sachetta, Director at Sensus Healthcare, bought ~$11K of Sensus Healthcare shares.

~$11K
Approx. value · 2,500 sh @ $4.50
133K
Holds after · shares reported
Traded
Nov 13, 2025
Filed
Nov 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  2. Nov 10, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 10, 2025, the Board of Directors (the “Board”) of Sensus Healthcare, Inc. (the “Company”) appointed Eric Sachetta as a Class II director of the Company for a term expiring at the Company’s annual meeting in 2026.”
  3. Nov 11, 2025Insider · 1 personInsiders: 5 purchases (~$13K)
  4. Nov 13, 2025 · this disclosureInsider · Their first buy on recordDirector purchased ~$11K of SRTS shares in the open market

What came next

  1. Nov 18, 2025Insider · 2 peopleInsiders: 2 purchases (~$105K)
  2. Nov 21, 2025Insider · 3 insiders in a week, 2nd time since 2016Director purchased ~$28K of SRTS shares in the open market
  3. Jan 5, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 5, 2026, the Board of Directors (the “Board”) of Sensus Healthcare, Inc. (the “Company”) appointed Larry Biscotti as a Class I director of the Company for a term expiring at the Company’s annual meeting in 2028.”
  4. Jan 13, 2026Company filing · Form 8-K · Auditor changeChanged its auditor“On January 13, 2026, the Audit Committee of the Company’s Board of Directors simultaneously dismissed BPB as the Company’s independent registered public accounting firm and approved the appointment of CRI as the Company’s independent registered public accounting firm.”
  5. Feb 12, 2026Company filing · Form 8-K · ResultsReported its results
  6. Feb 24, 2026InsiderDirector purchased ~$7.6K of SRTS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Sensus Healthcare

For Sensus Healthcare, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SRTS page.

Other recent filings by Eric Sachetta, Director

The full history of Eric Sachetta, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Sensus Healthcare

Everything OQRO holds on this company is on its SRTS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data